Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting ...Middle East

PR Newswire - News
Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
HMBD-002 is the only IgG4 isotype anti-VISTA antibody currently in development HMBD-002 is anticipated to enter a Phase 1 clinical trial in 2021 HOUSTON and SINGAPORE, May 30, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing...

Hence then, the article about hummingbird bioscience announces publication of abstract on anti vista antibody hmbd 002 at the american society of clinical oncology asco 2021 annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hummingbird Bioscience Announces Publication of Abstract on Anti-VISTA Antibody HMBD-002 at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting )

Apple Storegoogle play

Last updated :

Also on site :